Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-04

Clinical Trial Update: A Study of LY2541546 in Women With Low Bone Mineral Density [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY2541546 in women with low bone mineral density (osteoporosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2541546

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2017-12-04